PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,140 | -58.1% | 9,294 | -44.3% | 0.01% | -60.7% |
| Q1 2023 | $681,241 | -66.1% | 16,693 | -68.0% | 0.03% | -76.9% |
| Q4 2022 | $2,011,542 | +94.9% | 52,099 | +206.3% | 0.12% | +83.3% |
| Q2 2021 | $1,032,000 | -9.5% | 17,010 | +4.6% | 0.07% | +17.9% |
| Q1 2021 | $1,140,000 | +328.6% | 16,260 | +266.1% | 0.06% | +366.7% |
| Q4 2020 | $266,000 | +3.9% | 4,441 | +4.2% | 0.01% | 0.0% |
| Q3 2020 | $256,000 | -83.1% | 4,261 | -90.6% | 0.01% | -89.0% |
| Q1 2020 | $1,518,000 | -50.0% | 45,266 | -32.4% | 0.11% | -18.0% |
| Q4 2019 | $3,034,000 | -9.3% | 66,965 | -12.9% | 0.13% | -28.1% |
| Q2 2019 | $3,344,000 | +0.8% | 76,881 | -11.8% | 0.18% | -8.0% |
| Q1 2019 | $3,316,000 | +23.5% | 87,129 | +39.6% | 0.20% | -6.5% |
| Q4 2018 | $2,685,000 | -23.9% | 62,418 | -13.0% | 0.22% | -20.7% |
| Q3 2018 | $3,527,000 | +80.3% | 71,753 | +17.6% | 0.27% | +78.3% |
| Q2 2018 | $1,956,000 | +243.2% | 61,019 | +388.3% | 0.15% | +166.7% |
| Q1 2017 | $570,000 | -43.3% | 12,496 | -4.6% | 0.06% | -16.2% |
| Q4 2015 | $1,005,000 | – | 13,094 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |